Antipsychotic Drugs Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Antipsychotic Drugs Market to 2027 - Global Analysis and Forecasts By Drug Class (First Generation Drugs, Second generation Drugs, Third generation Drugs); Application (Schizophrenia, Bipolar Disorder, Dementia, Unipolar Depression, Other) and Geography

Report Code: TIPRE00005402 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Antipsychotics are also known as neuroleptics and tranquilizers, the class of medication used in treatment of psychosis includes schizophrenia, hallucinations, delusions and bipolar disorder and others. The antipsychotics are generally effective in relieving psychosis symptoms in short term, long term use of medication and is also associated with adverse effect such as gynecomastia, weight gain, impotence and involuntary movement disorder.

MARKET DYNAMICS
The antipsychotic drugs market is expected to grow in coming years owing to factors such as increase in prevalence of psychosis and disease associated with it, the introduction of new antipsychotics compounds by various market players, over prescription and addiction of antipsychotic drugs. On the other hand increase in government interest in research and development of antipsychotic drugs is expected to offer opportunities for growth of market.

MARKET SCOPE
The "Global Antipsychotic Drugs Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of antipsychotic drugs market with detailed market segmentation by drug class, application and geography. The global antipsychotic drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading antipsychotic drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global antipsychotic drugs market is segmented on the basis of drug class and application. Based on drug class, the market is segmented as first generation drugs, second generation drugs and third generation drugs. Based on application the antipsychotic drugs market is segmented as schizophrenia, bipolar disorder, dementia, unipolar depression and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global antipsychotic drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antipsychotic drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting antipsychotic drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antipsychotic drugs market market in these regions.

MARKET PLAYERS
The reports cover key developments in the antipsychotic drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antipsychotic drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for antipsychotic drugs in the global market. Below mentioned is the list of few companies engaged in the antipsychotic drugs market.

The report also includes the profiles of key antipsychotic drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Johnson and Johnson Services, Inc.
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • AstraZeneca
  • GlaxoSmithKline plc.
  • ALLERGAN
  • Actiza Pharmaceutical Private Limited
  • Biomax Biotechnics
  • Sun Pharmaceutical Industries Ltd.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antipsychotic Drugs Market - By Drug Class
1.3.2 Antipsychotic Drugs Market - By Application
1.3.3 Antipsychotic Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIPSYCHOTIC DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIPSYCHOTIC DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIPSYCHOTIC DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIPSYCHOTIC DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTIPSYCHOTIC DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG CLASS
7.1. OVERVIEW
7.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
7.3. FIRST GENERATION DRUGS
7.3.1. Overview
7.3.2. First Generation Drugs Market Forecast and Analysis
7.3.3. Thorazine (Chlorpromazine HCl) Market
7.3.3.1. Overview
7.3.3.2. Thorazine (Chlorpromazine HCl) Market Forecast and Analysis
7.3.4. Serentil (Mesoridazine Besylate) Market
7.3.4.1. Overview
7.3.4.2. Serentil (Mesoridazine Besylate) Market Forecast and Analysis
7.3.5. Mellaril (Thioridazine HCl) Market
7.3.5.1. Overview
7.3.5.2. Mellaril (Thioridazine HCl) Market Forecast and Analysis
7.3.6. Haldol (Haloperidol) Market
7.3.6.1. Overview
7.3.6.2. Haldol (Haloperidol) Market Forecast and Analysis
7.3.7. Loxitane (Loxapine Succinate) Market
7.3.7.1. Overview
7.3.7.2. Loxitane (Loxapine Succinate) Market Forecast and Analysis
7.3.8. Others Market
7.3.8.1. Overview
7.3.8.2. Others Market Forecast and Analysis
7.4. SECOND GENERATION DRUGS
7.4.1. Overview
7.4.2. Second generation Drugs Market Forecast and Analysis
7.4.3. Zyprexa (Olanzapine) Market
7.4.3.1. Overview
7.4.3.2. Zyprexa (Olanzapine) Market Forecast and Analysis
7.4.4. Geodon (Ziprasidone) Market
7.4.4.1. Overview
7.4.4.2. Geodon (Ziprasidone) Market Forecast and Analysis
7.4.5. Seroquel (Quetiapine) Market
7.4.5.1. Overview
7.4.5.2. Seroquel (Quetiapine) Market Forecast and Analysis
7.4.6. Risperdal (Risperidone) Market
7.4.6.1. Overview
7.4.6.2. Risperdal (Risperidone) Market Forecast and Analysis
7.4.7. Clozaril (Clozapine) Market
7.4.7.1. Overview
7.4.7.2. Clozaril (Clozapine) Market Forecast and Analysis
7.4.8. Others Market
7.4.8.1. Overview
7.4.8.2. Others Market Forecast and Analysis
7.5. THIRD GENERATION DRUGS
7.5.1. Overview
7.5.2. Third generation Drugs Market Forecast and Analysis
8. ANTIPSYCHOTIC DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SCHIZOPHRENIA
8.3.1. Overview
8.3.2. Schizophrenia Market Forecast and Analysis
8.4. BIPOLAR DISORDER
8.4.1. Overview
8.4.2. Bipolar Disorder Market Forecast and Analysis
8.5. DEMENTIA
8.5.1. Overview
8.5.2. Dementia Market Forecast and Analysis
8.6. UNIPOLAR DEPRESSION
8.6.1. Overview
8.6.2. Unipolar Depression Market Forecast and Analysis
8.7. OTHER
8.7.1. Overview
8.7.2. Other Market Forecast and Analysis
9. ANTIPSYCHOTIC DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Antipsychotic Drugs Market Overview
9.1.2 North America Antipsychotic Drugs Market Forecasts and Analysis
9.1.3 North America Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
9.1.4 North America Antipsychotic Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Antipsychotic Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Antipsychotic Drugs Market
9.1.5.1.1 United States Antipsychotic Drugs Market by Drug Class
9.1.5.1.2 United States Antipsychotic Drugs Market by Application
9.1.5.2 Canada Antipsychotic Drugs Market
9.1.5.2.1 Canada Antipsychotic Drugs Market by Drug Class
9.1.5.2.2 Canada Antipsychotic Drugs Market by Application
9.1.5.3 Mexico Antipsychotic Drugs Market
9.1.5.3.1 Mexico Antipsychotic Drugs Market by Drug Class
9.1.5.3.2 Mexico Antipsychotic Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Antipsychotic Drugs Market Overview
9.2.2 Europe Antipsychotic Drugs Market Forecasts and Analysis
9.2.3 Europe Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
9.2.4 Europe Antipsychotic Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Antipsychotic Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Antipsychotic Drugs Market
9.2.5.1.1 Germany Antipsychotic Drugs Market by Drug Class
9.2.5.1.2 Germany Antipsychotic Drugs Market by Application
9.2.5.2 France Antipsychotic Drugs Market
9.2.5.2.1 France Antipsychotic Drugs Market by Drug Class
9.2.5.2.2 France Antipsychotic Drugs Market by Application
9.2.5.3 Italy Antipsychotic Drugs Market
9.2.5.3.1 Italy Antipsychotic Drugs Market by Drug Class
9.2.5.3.2 Italy Antipsychotic Drugs Market by Application
9.2.5.4 Spain Antipsychotic Drugs Market
9.2.5.4.1 Spain Antipsychotic Drugs Market by Drug Class
9.2.5.4.2 Spain Antipsychotic Drugs Market by Application
9.2.5.5 United Kingdom Antipsychotic Drugs Market
9.2.5.5.1 United Kingdom Antipsychotic Drugs Market by Drug Class
9.2.5.5.2 United Kingdom Antipsychotic Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Antipsychotic Drugs Market Overview
9.3.2 Asia-Pacific Antipsychotic Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
9.3.4 Asia-Pacific Antipsychotic Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Antipsychotic Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Antipsychotic Drugs Market
9.3.5.1.1 Australia Antipsychotic Drugs Market by Drug Class
9.3.5.1.2 Australia Antipsychotic Drugs Market by Application
9.3.5.2 China Antipsychotic Drugs Market
9.3.5.2.1 China Antipsychotic Drugs Market by Drug Class
9.3.5.2.2 China Antipsychotic Drugs Market by Application
9.3.5.3 India Antipsychotic Drugs Market
9.3.5.3.1 India Antipsychotic Drugs Market by Drug Class
9.3.5.3.2 India Antipsychotic Drugs Market by Application
9.3.5.4 Japan Antipsychotic Drugs Market
9.3.5.4.1 Japan Antipsychotic Drugs Market by Drug Class
9.3.5.4.2 Japan Antipsychotic Drugs Market by Application
9.3.5.5 South Korea Antipsychotic Drugs Market
9.3.5.5.1 South Korea Antipsychotic Drugs Market by Drug Class
9.3.5.5.2 South Korea Antipsychotic Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Antipsychotic Drugs Market Overview
9.4.2 Middle East and Africa Antipsychotic Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
9.4.4 Middle East and Africa Antipsychotic Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Antipsychotic Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Antipsychotic Drugs Market
9.4.5.1.1 South Africa Antipsychotic Drugs Market by Drug Class
9.4.5.1.2 South Africa Antipsychotic Drugs Market by Application
9.4.5.2 Saudi Arabia Antipsychotic Drugs Market
9.4.5.2.1 Saudi Arabia Antipsychotic Drugs Market by Drug Class
9.4.5.2.2 Saudi Arabia Antipsychotic Drugs Market by Application
9.4.5.3 U.A.E Antipsychotic Drugs Market
9.4.5.3.1 U.A.E Antipsychotic Drugs Market by Drug Class
9.4.5.3.2 U.A.E Antipsychotic Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Antipsychotic Drugs Market Overview
9.5.2 South and Central America Antipsychotic Drugs Market Forecasts and Analysis
9.5.3 South and Central America Antipsychotic Drugs Market Forecasts and Analysis - By Drug Class
9.5.4 South and Central America Antipsychotic Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Antipsychotic Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Antipsychotic Drugs Market
9.5.5.1.1 Brazil Antipsychotic Drugs Market by Drug Class
9.5.5.1.2 Brazil Antipsychotic Drugs Market by Application
9.5.5.2 Argentina Antipsychotic Drugs Market
9.5.5.2.1 Argentina Antipsychotic Drugs Market by Drug Class
9.5.5.2.2 Argentina Antipsychotic Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTIPSYCHOTIC DRUGS MARKET, KEY COMPANY PROFILES
11.1. JOHNSON & JOHNSON SERVICES, INC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ELI LILLY AND COMPANY
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTRAZENECA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. GLAXOSMITHKLINE PLC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ALLERGAN
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ACTIZA PHARMACEUTICAL PRIVATE LIMITED
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. BIOMAX BIOTECHNICS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. SUN PHARMACEUTICAL INDUSTRIES LTD.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Johnson and Johnson Services, Inc.
2. Pfizer Inc.
3. Eli Lilly and Company
4. Bristol-Myers Squibb Company
5. AstraZeneca
6. GlaxoSmithKline plc.
7. ALLERGAN
8. Actiza Pharmaceutical Private Limited
9. Biomax Biotechnics
10. Sun Pharmaceutical Industries Ltd.